Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [28]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [28]
Citations
Cites
Disturbances in Lipid and Lipoprotein Metabolism
Bouchier, I. A. D. (1978) · Gut · doi:10.1136/gut.19.11.1088 · Cited by 495
Vetter, R. D., Carey, M. C., & Patton, J. S. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34356-x · Cited by 104
Laher, J. M., Rigler, M. W., Vetter, R. D., Barrowman, J. A., & Patton, J. S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34450-3 · Cited by 86
Lipid Absorption: Biochemical and Clinical Aspects
(1976) · Springer eBooks · doi:10.1007/978-94-011-7176-2 · Cited by 84
The Entry of Foreign Compounds into the Thoracic Duct Lymph of the Rat
Steber, S. M., Cohn, V. H., & Wynn, W. T. (1974) · Xenobiotica · doi:10.3109/00498257409052055 · Cited by 77
Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT
Charman, W. N., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90050-5 · Cited by 76
Self-citationSolubility of fatty acids and other hydrophobic molecules in liquid trioleoylglycerol.
Patton, J. S., Stone, B., Papa, C., Abramowitz, R., & Yalkowsky, S. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37839-1 · Cited by 69
Intestinal triglycerides are derived from both endogenous and exogenous sources
Shiau, Y. F., Popper, D. A., Reed, M., Umstetter, C., Capuzzi, D., & Levine, G. M. (1985) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1985.248.2.g164 · Cited by 68
Noguchi, T., Charman, W. N., & Stella, V. J. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90018-3 · Cited by 57
Self-citationThe Lymphatic Absorption of pp’-DDT and Some Structurally-Related Compounds in the Rat
Sieber, S. M. (1976) · Pharmacology · doi:10.1159/000136627 · Cited by 55
Cited by
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Self-citationFrom Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Charman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617
Self-citationHauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577
Self-citation
Metadata
- Authors
- Charman, W. N. A., & Stella, V. J.
- Affiliations
- University of Kansas (US)
- Corresponding author
- Stella, V.J.
- ORCID
- Charman, W.N.A.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 1986-12
- Volume
- 34
- Issue
- 1-2
- Pages
- 175-178
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W1968661040
- Cited by
- 217
- References
- 15
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 6 · 2014: 11 · 2013: 6 · 2012: 5
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- dolutegravir, ester prodrugs, long-chain triglycerides, mesenteric lymph nodes, intestinal lymphatic transport, lipophilic drug delivery, oral bioavailability, lipolysis, lipid-based drug delivery, antiretroviral drugs, pharmacokinetics, tissue distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. https://app.cochat.ai/papers/10.1016/0378-5173(86)90027-x
- The paper
- Charman, W. N. A., & Stella, V. J. (1986). Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. International Journal of Pharmaceutics. https://doi.org/10.1016/0378-5173(86)90027-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.